Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 13, 2026 18:13 ET | Source: Hagens Berman Sobol Shapiro LLP

Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss -- HBSS

Investors who lost money in ERAS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
July 12, 2026 17:53 ET | Source: The Rosen Law Firm PA

ROSEN, LEADING INVESTOR COUNSEL, Encourages Erasca, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ERAS

NEW YORK, July 12, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and...
July 10, 2026 13:34 ET | Source: Hagens Berman Sobol Shapiro LLP

Erasca (ERAS) Faces Securities Class Action After Stock Declines 48% on Drug Safety and IP Concerns-- HBSS

Investors who lost money in ERAS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
July 09, 2026 19:50 ET | Source: The Rosen Law Firm PA

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Erasca, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ERAS

NEW YORK, July 09, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and...
July 08, 2026 14:17 ET | Source: Hagens Berman Sobol Shapiro LLP

Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss -- HBSS

Investors who lost money in ERAS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
July 06, 2026 16:43 ET | Source: Hagens Berman Sobol Shapiro LLP

Erasca (ERAS) Faces Securities Class Action After Stock Declines 48% on Drug Safety and IP Concerns-- HBSS

Investors who lost money in ERAS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
July 03, 2026 19:49 ET | Source: The Rosen Law Firm PA

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Erasca, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ERAS

NEW YORK, July 03, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and...
July 03, 2026 14:19 ET | Source: Hagens Berman Sobol Shapiro LLP

Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss -- HBSS

Investors who lost money in ERAS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
June 30, 2026 19:10 ET | Source: Hagens Berman Sobol Shapiro LLP

Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss – Hagens Berman

Investors who lost money in ERAS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
June 26, 2026 18:31 ET | Source: Hagens Berman Sobol Shapiro LLP

Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss – Hagens Berman

Investors who lost money in ERAS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.